Compare PNC Financial Services Group Inc. (The) Common Stock (PNC) vs Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
PNC Financial Services Group Inc. (The) Common Stock vs Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) — how do they compare? PNC Financial Services Group Inc. (The) Common Stock trades at $220 (market cap $86.86B), while Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) trades at $18.35 (market cap $58.16B). The key difference: PNC Financial Services Group Inc. (The) Common Stock is the larger of the two by market cap, and PNC Financial Services Group Inc. (The) Common Stock pays the higher dividend (3.67%). Which is the better fit depends on your goals.
| PNC | TAK | |
|---|---|---|
Market Cap | $86.86B | $58.16B |
Volume | 2,044,725 | 2,467,530 |
Sector | Financials | Health |
52-Week High | $256.97 | $19.05 |
52-Week Low | $178.37 | $13.23 |
Enterprise Value | $143.85B | $86.04B |
Dividend Yield | 3.67% | 3.36% |
Typical Hold Time | — | 0 Days |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About PNC Financial Services Group Inc. (The) Common Stock
PNC Financial Services Group is a financial services holding company. Its businesses include retail banking, corporate and institutional banking, and asset management.
Read more on PNC →About Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)
Takeda is a Japanese pharmaceutical company developing medicines across areas including gastrointestinal disease, rare diseases, neuroscience, oncology, and plasma-derived therapies.
Read more on TAK →
